UiPath's fair value estimate has ticked higher from about $13.86 to $15.93 per share, even as analysts keep a neutral stance on the stock. Behind this shift are slightly higher required returns of ...

UiPath's consensus analyst price target has been modestly increased to $13.71 per share following the latest updates. This shift comes as experts weigh recent product announcements and revenue beats, ...

Robotic process automation (RPA) tools are paving the way for greater productivity, more precision, and accelerated digital transformation for businesses across all industries. There are many tools on ...

UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...

UiPath's strategic focus on long-term enterprise automation is driving positive outcomes, evident from record deals and strengthened partnerships. The integration of generative AI technologies and the ...

Back in early 2021, it seemed everything was going right for UiPath. At a time when there were a number of high-flying enterprise startups, UiPath was at the top of the heap when it raised $750 ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath helps businesses automate their workflows. The addressable market is expected to reach over $66 billion by 2032. UiPath's annual recurring revenue grew at a 24% rate in its most recent quarter.

The latest price target for UiPath (NYSE:PATH) was reported by Barclays on January 12, 2026. The analyst firm set a price target for $18.00 expecting PATH to rise to within 12 months (a possible 12.99 ...